BioPortUSA News and Event Updates

BioPortUSA announced a new partnership with GlobalMedHub a leading Middle East medtech consultancy based out of Dubai. GMH is strategically positioned to help international medtech companies from Europe and the U.S.A. to gain access to a challenging market.[...]

Oncgnostics is a leading Germany biotech company that specializes in the development of in vitro diagnostic tests for all areas of cancer diagnosis.[...]

BioPortUSA is pleased to announce the addition of two more subject matter experts to our team. Medical Device Academy is considered to be one of the top boutique FDA consultancies that also has a firm understanding of regulatory requirements from other countries around the world including CE and MDR marking. Mark Lesselroth, CEO of BioPortUSA said that “we are thrilled to have Rob Pakcard and his team on board not only because they can assist our international med-tech companies with 510K and De Novo applications but also because they have the ability to help our U.S. based clients with navigating the regulatory pathway in other parts of the world.”[...]

Nexterus (https://www.nexterus.com) is a leading, full-service supply chain logistics provider with a rich history of helping small to medium sized companies stay ahead of the competition by employing best in class supply chain strategies. Founded in 1948, the company is entering the 4th generation of leadership.[...]